Fludarabine, low-dose busulfan and antithymocyte globulin as conditioning for Fanconi anemia patients receiving bone marrow transplantation from HLA-compatible related donors

MLA

Alexander Rumiantsev, et al. “Fludarabine, Low-Dose Busulfan and Antithymocyte Globulin as Conditioning for Fanconi Anemia Patients Receiving Bone Marrow Transplantation from HLA-Compatible Related Donors.” Bone Marrow Transplantation, vol. 34, June 2004, pp. 305–07. EBSCOhost, https://doi.org/10.1038/sj.bmt.1704580.

APA

Alexander Rumiantsev, Y.V. Skvortsova, Alexey Maschan, Pavel Trakhtman, Z M Dyshlevaja, E V Skorobogatova, I. Shipicina, E V Samochatova, & Dmitry Balashov. (2004). Fludarabine, low-dose busulfan and antithymocyte globulin as conditioning for Fanconi anemia patients receiving bone marrow transplantation from HLA-compatible related donors. Bone Marrow Transplantation, 34, 305–307. https://doi.org/10.1038/sj.bmt.1704580

Chicago

Alexander Rumiantsev, Y.V. Skvortsova, Alexey Maschan, Pavel Trakhtman, Z M Dyshlevaja, E V Skorobogatova, I. Shipicina, E V Samochatova, and Dmitry Balashov. 2004. “Fludarabine, Low-Dose Busulfan and Antithymocyte Globulin as Conditioning for Fanconi Anemia Patients Receiving Bone Marrow Transplantation from HLA-Compatible Related Donors.” Bone Marrow Transplantation 34 (June): 305–7. doi:10.1038/sj.bmt.1704580.